{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:01:17Z","timestamp":1776816077002,"version":"3.51.2"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02283","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:34:07Z","timestamp":1538958847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Rapamycin Nano-Micelle Ophthalmic Solution Reduces Corneal Allograft Rejection by Potentiating Myeloid-Derived Suppressor Cells' Function"],"prefix":"10.3389","volume":"9","author":[{"given":"Chao","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demeng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianggen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"B1","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.4049\/jimmunol.1600251","article-title":"Alloimmunity and tolerance in corneal transplantation","volume":"196","author":"Amouzegar","year":"2016","journal-title":"J Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000099279","article-title":"Immunogenicity and immune privilege of corneal allografts","volume":"92","author":"Hori","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","article-title":"Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation","volume":"152","author":"Shimazki Den","year":"2011","journal-title":"Am J Ophthalmol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(01)00759-X","article-title":"Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts","volume":"108","author":"Sloper","year":"2001","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1097\/TP.0b013e3181903b0a","article-title":"All contributors. risk factors for human corneal graft failure within the Australian corneal graft registry","volume":"86","author":"Williams","year":"2008","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"CD007603","DOI":"10.1002\/14651858.CD007603.pub2","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty","volume":"8","author":"Abudou","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","article-title":"mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review","volume":"64","author":"Weichhart","year":"2017","journal-title":"Gerontology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer","volume":"137","author":"Mabuchi","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/ajt.13151","article-title":"Evolving perspectives of mTOR complexes in immunity and transplantation","volume":"15","author":"Fantus","year":"2015","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"E975","DOI":"10.3390\/ijms17060975","article-title":"Role of mTOR Inhibitors in Kidney Disease","volume":"17","author":"Kajiwara","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1136\/hrt.2009.172379","article-title":"Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results","volume":"95","author":"Byrne","year":"2009","journal-title":"Heart"},{"key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/01.tp.0000191291.71003.1b","article-title":"An open prospective pilot study on the use of rapamycin after penetrating high-risk kearatoplasty","volume":"81","author":"Birnbaum","year":"2006","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.6002\/ect.2012.0025","article-title":"Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4 (+) CD25 (+) Foxp3 (+) regulatory T cells","volume":"11","author":"Wang","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ajo.2010.03.010","article-title":"Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk","volume":"150","author":"Chatel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000150444","article-title":"Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty","volume":"40","author":"Li","year":"2008","journal-title":"Ophthalmic Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00417-010-1420-z","article-title":"Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival","volume":"248","author":"Stanojlovic","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1167\/iovs.05-1425","article-title":"Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits","volume":"47","author":"Shi","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/jphp.12089","article-title":"Rapamycin-loaded poly(\u03b5-caprolactone)-poly(ethylene glycol)-poly(\u03b5-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation","volume":"66","author":"Zhang","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00417-010-1403-0","article-title":"Establishment of a murine model of chronic corneal allograft dysfunction","volume":"248","author":"Gao","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.1038\/srep12968","article-title":"Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.18632\/aging.101050","article-title":"TGF-\u03b2 and NF-\u03baB signaling pathway crosstalk potentiates corneal epithelial senescence through an RNA stress response","volume":"8","author":"Li","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1097\/TP.0000000000000749","article-title":"Effects of adoptive transferring different sources of myeloid-derived suppressor cells in mice corneal transplant survival","volume":"99","author":"He","year":"2015","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.trim.2015.12.003","article-title":"The roles of sepsis-induced myeloid derived suppressor cells in mice corneal, skin and combined transplantation","volume":"34","author":"He","year":"2016","journal-title":"Transpl Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1189\/jlb.5A1115-508RR","article-title":"Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve cornealallograft survival","volume":"100","author":"Choi","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1111\/ajt.13276","article-title":"Rapamycin prolongs cardiac allograft survival in a mouse model by inducing myeloid-derived suppressor cells","volume":"15","author":"Nakamura","year":"2015","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1038\/cddis.2017.86","article-title":"The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1189\/jlb.0913473","article-title":"mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury","volume":"95","author":"Zhang","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"16468","DOI":"10.1038\/srep16468","article-title":"Development and effects of FTY720 ophthalmic solution on corneal allograft survival","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00002018-200528020-00006","article-title":"Benefit-risk assessment of sirolimus in reneal transplantation","volume":"28","author":"Kuypers","year":"2005","journal-title":"Drug saf"},{"key":"B35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.11622\/smedj.2013104","article-title":"Occurrence of a lymphocele following renal transplantation","volume":"54","author":"Sim","year":"2013","journal-title":"Singapore Med J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/jop.2015.0047","article-title":"Recent advances in topical ocular drug delivery","volume":"32","author":"Yellepeddi","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/ICU.0b013e328330ccb9","article-title":"Recent advances in drug delivery systems for treating ocular complications of systemic diseases","volume":"20","author":"Lee","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.toxlet.2012.05.004","article-title":"A new cell-based method for assessing the eye irritation potential of chemicals: an alternative to the Draize test","volume":"212","author":"Cho","year":"2012","journal-title":"Toxicol Lett"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/TP.0000000000001529","article-title":"C-C Chemokine receptor type 2 (CCR2)-dependent migration of myeloid-derived suppressor cells in protection of islet transplants","volume":"101","author":"Qin","year":"2017","journal-title":"Transplantation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15026","article-title":"Glucocorticoids induce corneal allograft tolerance through expansion of monocytic myeloid-derived suppressor cells","author":"Lee","year":"2018","journal-title":"Am J Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int J Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1189\/jlb.0311177","article-title":"Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice","volume":"91","author":"Youn","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1182\/blood-2014-09-599266","article-title":"Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg","volume":"125","author":"Biswas","year":"2015","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:34:13Z","timestamp":1538958853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2018.02283"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02283","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"article-number":"2283"}}